Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 4, 2002, Pages 904-912

  Kupelian, Patrick A ^a   Reddy, Chandana A ^a   Carlson, Thomas P ^a   Altsman, Kimberley A ^a   Willoughby, Twyla R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Intensity modulation; Local therapy; Prostatic neoplasms; PSA relapse; Radiotherapy

Indexed keywords

ANTIGENS; RADIATION; RADIOTHERAPY; TISSUE; TOXICITY; TUMORS;

DOSE ESCALATION;

ONCOLOGY;

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

AGE; ANALYTIC METHOD; ARTICLE; BIOCHEMISTRY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CAUTERIZATION; CLINICAL TRIAL; COLLIMATOR; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROTEIN ANALYSIS; RADIATION DOSE; RECTUM HEMORRHAGE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TIME; TOXICITY; TREATMENT OUTCOME; ULTRASOUND;

AGED; COHORT STUDIES; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RECURRENCE; TIME FACTORS;

EID: 0037100155     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02836-5     Document Type: Article

References (22)

1. Conformal radiotherapy for prostate cancer
2. Improvement in overall survival for patients with localized prostate cancer with higher than standard radiation doses: Preliminary results
3. Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6, and pretreatment prostate-specific antigen < or = 10)
4. Higher than standard radiation doses (72 Gy or greater) with or without androgen deprivation in the treatment of localized prostate cancer
5. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
6. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate
7. Fractionation and protraction for radiotherapy of prostate carcinoma
8. Is the alpha/beta ratio for prostate cancer low?
9. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy
10. A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low
11. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland
12. Short-course intensity-modulated radiotherapy for localized prostate cancer
13. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer
14. Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer
15. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
16. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report
17. Extent of extracapsular extension in localized prostate cancer
18. The radial distance of extraprostatic extension of prostate carcinoma: Implications for prostate brachytherapy
19. Hypofractionation for prostate cancer
20. Three-dimensional conformal radiotherapy, and dose escalation: Where do we stand?
21. Locally advanced prostatic cancer: Long-term toxicity outcome after three-dimensional conformal radiation therapy - A dose-escalation study